This is an opportunity to acquire a reputable full-service CRO (clinical research organization) for pharmaceuticals and for medical device programs, offering clinical, statistical and regulatory support from concept to market approval. The Company boasts a large number of returning clients, which ensures consistent demand and revenue year after year. Furthermore, their highly qualified staff of experts with over 25 years in the industry and a longstanding track record of excellence will provide a smooth transition for incoming ownership. The company is currently based in Pennsylvania. Their geographic footprint includes clients in the U.S., Canada, and Europe.
Tremendous untapped potential exists in the licensing of its proprietary technology and the establishment of a new revenue stream of software and data licensing. Moreover, given that the Company’s current client acquisition strategy relies mostly on word of mouth, implementing marketing and sales campaigns, coupled with hiring experienced personnel in clinical development, could lead to a seamless scaling of operations.
The current owners are seeking a full sale as they are nearing retirement and are searching for a new owner who will commit to scaling the business that they have established and led for over 25 years.
